Intervention

fluoxetine

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 11 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials11

Recruiting0

Common conditions10

Lead sponsors shown8

Clinical trials

11 shown

Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in GhanaNCT02593734 · 2013-07-01

COMPLETED

Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major DepressionNCT01824433 · 2013-03-07

COMPLETED

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDNCT01372150 · 2011-11-17

COMPLETED

A Study in the Treatment of Children and Adolescents With Major Depressive DisorderNCT00849901 · 2009-03-01

COMPLETED

A Study in the Treatment of Children and Adolescents With Major Depressive DisorderNCT00849693 · 2009-03-01

COMPLETED

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe DepressionNCT00666757 · 2008-05-01

COMPLETED

Early Prediction of Fluoxetine ResponseNCT01075529 · 2007-03-01

COMPLETED

Fluoxetine and Bupropion to Treat Patients With Depression and AlcoholismNCT00449007 · 2006-02-01

TERMINATED

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerNCT00005850 · 2001-08-01

COMPLETED

Prozac Treatment of Major Depression: Discontinuation StudyNCT00427128 · 1995-11-01

COMPLETED

Neurophysiologic Monitoring of Antidepressant TreatmentNCT01360190 · 1994-08-01

COMPLETED

Common conditions

Major Depressive Disorder5 Depression3 Anxiety Disorder2 Major Depression2 Alcoholism1 Fatigue1 Lung Cancer1 Mood Disorders,1 Schizophrenia1 Suicidal Behavior1

Leading sponsors

Eli Lilly and Company3 New York State Psychiatric Institute2 Alliance for Clinical Trials in Oncology1 Capital Medical University1 Kaohsiung Kai-Suan Psychiatric Hospital1 Pfizer1 University of California, Los Angeles1 University of Ghana Medical School1

Trial status mix

COMPLETED10

TERMINATED1

Phase mix

PHASE47

PHASE33

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.